Related Experiment Video
Updated: Jun 20, 2026
19:15
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
NEWBORN ATTENTION AS AFFECTED BY MEDICATION DURING LABOR
Science (New York, N.Y.)
|April 17, 1964
Summary
Newborns exposed to heavy labor medication showed reduced attentiveness. Light medication during childbirth was associated with more alert infants in the first few days of life.
Area of Science:
- Neonatal studies
- Developmental psychology
- Obstetric medicine
Background:
- Maternal medication during labor can impact neonatal outcomes.
- Assessing infant neurobehavioral responses is crucial for understanding early development.
Purpose of the Study:
- To investigate the association between maternal medication dosage during labor and infant attentiveness.
- To compare the neurobehavioral state of newborns exposed to heavy versus light maternal medication.
Main Methods:
- Observational study comparing two groups of newborns (2-4 days old).
- Mothers were categorized based on the amount of medication received during labor (heavy vs. light).
- Infant attentiveness was assessed using standardized observational methods.
Main Results:
- Newborns whose mothers received heavy labor medication exhibited significantly lower attentiveness.
- Infants born to mothers with light medication showed higher levels of alertness and responsiveness.
- A dose-dependent relationship between medication and attentiveness may exist.
Conclusions:
- Heavy maternal medication during labor is linked to decreased attentiveness in newborns.
- Minimizing medication during childbirth may support optimal early infant neurobehavioral development.
- Further research is warranted to explore the long-term effects and specific mechanisms.
Keywords:
ALPHAPRODINEANALGESICS AND ANTIPYRETICSATTENTIONINFANT, NEWBORNLABORMEPERIDINEPENTOBARBITALPHARMACOLOGYPREGNANCYPROMETHAZINETOXICOLOGIC REPORTVISUAL PERCEPTIONMore Related Videos
09:43The 5-Choice Serial Reaction Time Task: A Task of Attention and Impulse Control for Rodents
Published on: August 10, 2014
10:02Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)
Published on: March 12, 2020
Related Concept Videos
01:21Factors Affecting Drug Response: Overview
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...